All Clinical Resources

1 - 12 of 232 results
Man holding his back

Recognizing IBP (inflammatory back pain) vs MBP (mechanical back pain)

An Adaptive Learning Experience Sponsored by Novartis Pharmaceutical Corporation; Not for CME/CE Credit

Axial spondyloarthritis (axSpA) is a chronic and debilitating inflammatory disease primarily affecting the spine and sacroiliac joints. In the United States alone, it is estimated to take 14 years to receive appropriate diagnosis as it's hallmark symptom, inflammatory back pain, can go unnoticed or be misdiagnosed. Due to the challenges in recognizing axSpA, patients are often referred to various healthcare providers in the journey to diagnosis. There is a significant need to increase the proper diagnosis of axSpA among healthcare professionals, especially those that are seeing patients experiencing back pain. Early identification and timely referral to rheumatologists can help mitigate the progressive structural damage and significant patient burden in axSpA patients.

The Continuum of Heart Failure

Industry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Not for CME/CE Credit

The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.

Cardiovascular Disease Journey. “It’s the Little Things”: A Tale of Two Patients

Industry Webcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

This program follows two patients on their cardiovascular disease (CVD) journeys. Risk factors leading to the development and progression of atherosclerotic CVD and heart failure are discussed in the context of the patient experience over time. Strategies for primary and secondary prevention and optimization of guideline-directed medical therapy are also highlighted.

Image of skull and neck with arteries highlighting

Clinical Considerations in Coronary Artery Disease

Industry Webcast Sponsored by AstraZeneca Pharmaceuticals, LP; Not for CME/CE Credit

• Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA). • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial

computer drawing of a heart

Primary Care Heart Failure Learning Module

An Adaptive Learning Experience Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

Heart failure (HF) is a complex syndrome brought on by impairment of the structure or function of ventricular filling or blood ejection. These changes can significantly decrease quality of life, resulting in edema, dyspnea, and fatigue. The disease is widespread and progresses in severity, resulting in significant morbidity and mortality. This course is built on the latest HF guidelines and seeks to help learners better understand this prevalent, serious disease. Topics include pathophysiology, etiology, and epidemiology, morbidity and mortality, diagnosis through the use of biomarkers and other screening tools, impact of HF hospitalization, hospitalization care goals and team-based care.

An Evolving Treatment Paradigm for Chronic Heart Failure in Primary Care

Industry Webcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

This program will review recent developments in the treatment of patients with chronic heart failure and discuss the important role of the primary care physician.

Early Recognition of axSpA in Primary Care Chapter 5: Importance of Screenings Tools for Referrals

Industry Webcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

This webinar will educate primary care physicians on screening tools for assessment of axial spondyloarthritis, including referral strategies presented by the Assessment of SpondyloArthritis international Society (ASAS) and the Prevalence of Axial Spondyloarthritis (PROSpA) to help inform decisions on appropriate referrals to rheumatologists. This is the fifth chapter of a series of videos exploring early recognition of axSpA. Join us for a live webinar with Dr. Danve and Dr. Magrey on May 15.

Pancreatic Cancer & Primary Care: Identifying & Managing High-Risk Patients

Industry Webcast Sponsored by Immunovia, Inc.; Not for CME/CE Credit

During this presentation, Dr. Giles Whalen, a Surgical Oncologist, will review which patients are at highest risk for developing pancreatic cancer and how primary care providers can assist those patients. Dr. Whalen will also review which patients should be referred for genetic counseling or to a high risk screening program for pancreatic cancer surveillance. Dr. Tom King will then provide an overview of the IMMray® PanCan-d test, a blood test for the early detection of pancreatic ductal adenocarcinoma in individuals at high risk for developing familial or hereditary pancreatic cancer.

Revisiting the Use of Oral Corticosteroids in Asthma: Benefits and Risks

Industry Webcast Sponsored by AstraZeneca; Not for CME/CE Credit

• Examine the medical burden of influenza and its economic impact in adults 50+ years of age • Explore how influenza can exacerbate chronic health conditions and lead to adverse outcomes • Review clinical evidence of 2 influenza vaccines that were compared to standard-dose influenza vaccines in older adults

computer drawing of a heart

Hospitalization: An Opportunity to Optimize Care for Patients with Heart Failure

Industry Webcast Sponsored by Novartis; Not for CME/CE Credit

computer drawing of a heart

Heart Failure with Preserved Ejection Fraction (HFpEF): An Overview

Industry Webcast Sponsored by Novartis; Not for CME/CE Credit